Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
63°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
1.280
-0.120 (-8.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neumora Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
March 07, 2025
Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion
Via
Benzinga
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
January 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 02, 2025
Via
Benzinga
Crude Oil Surges 2%; Tesla Shares Plummet
January 02, 2025
Via
Benzinga
Exposures
Fossil Fuels
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Nasdaq Dips Over 100 Points; Unity Software Shares Jump
January 02, 2025
Via
Benzinga
Dow Surges Over 300 Points; US Initial Jobless Claims Decline
January 02, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops
January 02, 2025
The company said it plans to investigate a positive signal from female patients.
Via
Investor's Business Daily
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
January 02, 2025
Via
Benzinga
Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials
January 02, 2025
Neumora's KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and updates are anticipated.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 18, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
Via
Benzinga
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024
August 06, 2024
NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024
May 07, 2024
NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...
Via
Benzinga
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
April 15, 2024
Neumora Therapeutics faces setbacks as FDA halts Phase 1 trial of NMRA-266 due to convulsion concerns in rabbits. Phase 1 study paused; company working with FDA for resolution.
Via
Benzinga
Exposures
Product Safety
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.
Via
Investor's Business Daily
Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?
April 15, 2024
Mobile Global Esports stock is falling on Monday after the company revealed that shares of MGAM will be delisted later this week.
Via
InvestorPlace
Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
April 15, 2024
Neumora Therapeutics stock is falling on Monday as investors in NMRA shares react to a clinical trial being put on hold by the FDA.
Via
InvestorPlace
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 13, 2024
Via
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...
Via
Benzinga
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
March 13, 2024
U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023
March 07, 2024
NMRA stock results show that Neumora Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.